Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 8
1981 2
1982 10
1983 11
1984 19
1985 14
1986 13
1987 33
1988 20
1989 22
1990 22
1991 25
1992 31
1993 18
1994 22
1995 27
1996 19
1997 20
1998 16
1999 19
2000 11
2001 20
2002 20
2003 22
2004 22
2005 17
2006 26
2007 33
2008 26
2009 22
2010 31
2011 29
2012 31
2013 38
2014 34
2015 23
2016 16
2017 12
2018 12
2019 17
2020 8
2021 4
2022 1
2023 3
2024 1
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

798 results

Results by year

Filters applied: . Clear all
Page 1
Ketoconazole shampoo: effect of long-term use in androgenic alopecia.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE. Piérard-Franchimont C, et al. Dermatology. 1998;196(4):474-7. doi: 10.1159/000017954. Dermatology. 1998. PMID: 9669136 Clinical Trial.
OBJECTIVE: The aim of our study was to determine if ketoconazole (KCZ) which is active against the scalp microflora and shows some intrinsic anti-inflammatory activity might improve alopecia. ...
OBJECTIVE: The aim of our study was to determine if ketoconazole (KCZ) which is active against the scalp microflora and shows some in …
Ketoconazole and pulmonary failure after esophagectomy: a prospective clinical trial.
Schilling MK, Eichenberger M, Maurer CA, Sigurdsson G, Büchler MW. Schilling MK, et al. Dis Esophagus. 2001;14(1):37-40. doi: 10.1111/j.1442-2050.2001.00158.x. Dis Esophagus. 2001. PMID: 11422304 Clinical Trial.
Thirty-eight consecutive patients undergoing esophageal resection were treated pre- and perioperatively with 3 x 200 mg ketoconazole. The clinical course was studied and pulmonary function was assessed according to the Murray score. ...Two out of 38 ketoconazole-tre …
Thirty-eight consecutive patients undergoing esophageal resection were treated pre- and perioperatively with 3 x 200 mg ketoconazole. …
Impact of vaginal microbiota on the clinical efficacy and long-term recurrence of ketoconazole suppositories in treating severe vulvovaginal candidiasis: a secondary analysis of a multicentre randomised trial.
Mi L, Zhang D. Mi L, et al. Front Cell Infect Microbiol. 2025 Nov 24;15:1638454. doi: 10.3389/fcimb.2025.1638454. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 41368434 Free PMC article. Clinical Trial.
A total of 253 patients diagnosed with severe vulvovaginal candidiasis were enrolled. The study group received ketoconazole suppositories, while the control group received miconazole nitrate vaginal capsules. ...In the treatment of severe vulvovaginal candidiasis, ketoc …
A total of 253 patients diagnosed with severe vulvovaginal candidiasis were enrolled. The study group received ketoconazole supposito …
Single- and multiple-dose pharmacokinetics of bosentan and its interaction with ketoconazole.
van Giersbergen PL, Halabi A, Dingemanse J. van Giersbergen PL, et al. Br J Clin Pharmacol. 2002 Jun;53(6):589-95. doi: 10.1046/j.1365-2125.2002.01608.x. Br J Clin Pharmacol. 2002. PMID: 12047483 Free PMC article. Clinical Trial.
Treatment B consisted of bosentan (62.5 mg twice daily) for 5.5 days plus concomitant ketoconazole (200 mg once daily) for 6 days. Plasma concentrations of bosentan and its three metabolites were measured on days 1 and 7 of treatment A and on day 6 of treatment B. ...Upon …
Treatment B consisted of bosentan (62.5 mg twice daily) for 5.5 days plus concomitant ketoconazole (200 mg once daily) for 6 days. Pl …
Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.
Lee JS, Newman RA, Lippman SM, Fossella FV, Calayag M, Raber MN, Krakoff IH, Hong WK. Lee JS, et al. J Clin Oncol. 1995 Jun;13(6):1501-8. doi: 10.1200/JCO.1995.13.6.1501. J Clin Oncol. 1995. PMID: 7751898 Clinical Trial.
This accelerated metabolism has been shown to be inhibited in the short term by the cytochrome P450 inhibitor ketoconazole. This study was conducted to evaluate the efficacy of ketoconazole in maintaining plasma all-trans RA levels over time. ...This lack of effect …
This accelerated metabolism has been shown to be inhibited in the short term by the cytochrome P450 inhibitor ketoconazole. This stud …
Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
Greenblatt DJ, Wright CE, von Moltke LL, Harmatz JS, Ehrenberg BL, Harrel LM, Corbett K, Counihan M, Tobias S, Shader RI. Greenblatt DJ, et al. Clin Pharmacol Ther. 1998 Sep;64(3):237-47. doi: 10.1016/S0009-9236(98)90172-2. Clin Pharmacol Ther. 1998. PMID: 9757147 Clinical Trial.
METHODS: In a double-blind, 5-way crossover study, healthy volunteers received (A) ketoconazole placebo plus 1.0 mg alprazolam orally, (B) 200 mg ketoconazole twice a day plus 1.0 mg alprazolam, (C) ketoconazole placebo plus 0.25 mg triazolam orally, (D) 200 …
METHODS: In a double-blind, 5-way crossover study, healthy volunteers received (A) ketoconazole placebo plus 1.0 mg alprazolam orally …
A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients.
Womble PR, VanVeldhuizen PJ, Nisbet AA, Reed GA, Thrasher JB, Holzbeierlein JM. Womble PR, et al. J Urol. 2011 Sep;186(3):882-7. doi: 10.1016/j.juro.2011.04.087. Epub 2011 Jul 24. J Urol. 2011. PMID: 21791342 Clinical Trial.
For 12 weeks they were treated with neoadjuvant docetaxel and ketoconazole, with dosing based on phase I data. Patients were monitored for tolerance of therapy and dosing adjustments were made for significant toxicities. ...However, 16 patients completed all 4 cycles of ch …
For 12 weeks they were treated with neoadjuvant docetaxel and ketoconazole, with dosing based on phase I data. Patients were monitore …
Fluconazole and testosterone: in vivo and in vitro studies.
Hanger DP, Jevons S, Shaw JT. Hanger DP, et al. Antimicrob Agents Chemother. 1988 May;32(5):646-8. doi: 10.1128/AAC.32.5.646. Antimicrob Agents Chemother. 1988. PMID: 2840013 Free PMC article. Clinical Trial.
Similarly, in studies with rat Leydig cells in vitro, fluconazole at concentrations up to 10 micrograms/ml was found to be only a weak inhibitor of testosterone production, whereas ketoconazole caused more than 50% inhibition at 0.1 microgram/ml. It is concluded that fluco …
Similarly, in studies with rat Leydig cells in vitro, fluconazole at concentrations up to 10 micrograms/ml was found to be only a weak inhib …
Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial.
Peter RU, Richarz-Barthauer U. Peter RU, et al. Br J Dermatol. 1995 Mar;132(3):441-5. doi: 10.1111/j.1365-2133.1995.tb08680.x. Br J Dermatol. 1995. PMID: 7718463 Clinical Trial.
We performed a multicentre study to investigate the efficacy of ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoeic dermatitis and dandruff. ...These patients were treated with the active preparation (shampoo containing 2% ketoconazole) once-week …
We performed a multicentre study to investigate the efficacy of ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoe …
798 results